BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29359881)

  • 1. 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.
    Porpiglia F; Fiori C; Bertolo R; Giordano A; Checcucci E; Garrou D; Cattaneo G; De Luca S; Amparore D
    BJU Int; 2018 Jul; 122(1):106-112. PubMed ID: 29359881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
    Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
    World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.
    De Nunzio C; Cantiello F; Fiori C; Crocerossa F; Tognoni P; Amparore D; Baldassarri V; Elbers JR; Sancha FG; Porpiglia F
    World J Urol; 2021 Jun; 39(6):2037-2042. PubMed ID: 32851439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's New in TIND?
    Marcon J; Magistro G; Stief CG; Grimm T
    Eur Urol Focus; 2018 Jan; 4(1):40-42. PubMed ID: 29705283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction.
    Amparore D; Fiori C; Valerio M; Schulman C; Giannakis I; De Cillis S; Kadner G; Porpiglia F
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):349-357. PubMed ID: 33005003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First- and Second-Generation Temporary Implantable Nitinol Devices As Minimally Invasive Treatments for BPH-Related LUTS: Systematic Review of the Literature.
    Amparore D; De Cillis S; Volpi G; Checcucci E; Manfredi M; Morra I; Di Dio M; Fiori C; Porpiglia F;
    Curr Urol Rep; 2019 Jul; 20(8):47. PubMed ID: 31278441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia.
    Vjaters E; Nitsan D; Mullerad M; Engelstein D; Leibovitch I; Feld Y
    Eur Urol Focus; 2020 Jan; 6(1):131-136. PubMed ID: 30293945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of Temporary Implantable Nitinol Device (TIND) Implantation for the Treatment of BPH: a Systematic Review.
    Bertolo R; Fiori C; Amparore D; Porpiglia F
    Curr Urol Rep; 2018 Apr; 19(6):44. PubMed ID: 29700686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robot-assisted simple prostatectomy for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: surgical technique and outcomes in a high-volume robotic centre.
    Pokorny M; Novara G; Geurts N; Dovey Z; De Groote R; Ploumidis A; Schatteman P; de Naeyer G; Mottrie A
    Eur Urol; 2015 Sep; 68(3):451-7. PubMed ID: 25887786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results.
    Amparore D; De Cillis S; Schulman C; Kadner G; Fiori C; Porpiglia F
    Minerva Urol Nephrol; 2023 Dec; 75(6):743-751. PubMed ID: 37350585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
    Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
    Reale G; Marchioni M; Altieri V; Greco F; De Nunzio C; Destefanis P; Ricciardulli S; Bergamaschi F; Fasolis G; Varvello F; Voce S; Palmieri F; Divan C; Malossini G; Oriti R; Tuccio A; Ruggera L; Tubaro A; Delicato G; Laganà A; Dadone C; De Rienzo G; Ditonno A; Frattini A; Pucci L; Carrino M; Montefiore F; Germani S; Miano R; Schips L; Rabito S; Ferrari G; Cindolo L
    Minerva Urol Nefrol; 2020 Oct; 72(5):622-628. PubMed ID: 32284526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Madersbacher S; Roehrborn CG; Oelke M
    BJU Int; 2020 Sep; 126(3):317-326. PubMed ID: 32599656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
    Desai MM; Singh A; Abhishek S; Laddha A; Pandya H; Ashrafi AN; Ganpule AP; Roehrborn CG; Thomas AJ; Desai M; Sabnis RB
    BJU Int; 2018 Jun; 121(6):945-951. PubMed ID: 29319914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.